Home > Insider Trading > Filing (0001466049-11-000069)

Filing Details

Accession Number:: 0001466049-11-000069
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-21 16:54:45
Reporting Period:: 2011-09-19

Filing Date:: 2011-09-21
Accepted Time:: 2011-09-21 16:54:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Biodel Inc	BIOD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304170	Solomon Steiner	C/O Biodel Inc. 100 Saw Mill Road Danbury CT 06810		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2011-09-19	190,700	$1.19	1,811,622	No	4	S	Direct
Common Stock	Disposition	2011-09-20	82,723	$1.17	1,728,899	No	4	S	Direct
Common Stock	Disposition	2011-09-21	43,094	$1.15	1,685,805	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $1.19 to $1.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to proivde upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the tranaction was reflected.
This transaction was executed in multiple trades at prices ranging from $1.15 to $1.21 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to proivde upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the tranaction was reflected.
The sales reported in this transaction were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2011. This transaction was executed in multiple trades at prices ranging from $1.13 to $1.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to proivde upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the tranaction was reflected.
The amount shown represents shares of the Issuer beneficially owned by Steiner Ventures, LLC. which shares may be deemed attributable to the Reporting Person because the Reporting Person is the sole managing member of Steiner Ventures, LL. The Reporting Person disclaims beneificial ownership except to the extent of his pecuniary interest therein.